These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32286949)

  • 1. Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
    Imprialos K; Koutsampasopoulos K; Manolis A; Doumas M
    Curr Vasc Pharmacol; 2021; 19(3):301-312. PubMed ID: 32286949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases.
    Cai Z; Zhang J; Li H
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the association between erectile dysfunction and cardiovascular disease.
    Gandaglia G; Briganti A; Jackson G; Kloner RA; Montorsi F; Montorsi P; Vlachopoulos C
    Eur Urol; 2014 May; 65(5):968-78. PubMed ID: 24011423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy.
    Imprialos KP; Stavropoulos K; Doumas M; Tziomalos K; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2018 Jan; 16(2):130-142. PubMed ID: 28595561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management.
    Hernández-Cerda J; Bertomeu-González V; Zuazola P; Cordero A
    Vasc Health Risk Manag; 2020; 16():231-239. PubMed ID: 32606719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and perspectives in erectile dysfunction in man.
    Mitidieri E; Cirino G; d'Emmanuele di Villa Bianca R; Sorrentino R
    Pharmacol Ther; 2020 Apr; 208():107493. PubMed ID: 31991196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile Dysfunction and Subclinical Cardiovascular Disease.
    Miner M; Parish SJ; Billups KL; Paulos M; Sigman M; Blaha MJ
    Sex Med Rev; 2019 Jul; 7(3):455-463. PubMed ID: 29396281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?
    Pozzi E; Capogrosso P; Boeri L; Belladelli F; Baudo A; Schifano N; Abbate C; Dehò F; Montorsi F; Salonia A
    J Sex Med; 2020 Aug; 17(8):1489-1494. PubMed ID: 32340919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile Dysfunction Predicts Cardiovascular Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis.
    Zhao B; Hong Z; Wei Y; Yu D; Xu J; Zhang W
    J Sex Med; 2019 Jul; 16(7):1005-1017. PubMed ID: 31104857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapeutic management of erectile dysfunction.
    Hawksworth DJ; Burnett AL
    Clin Pharmacol Ther; 2015 Dec; 98(6):602-10. PubMed ID: 26352006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact.
    Voznesensky I; DeLay KJ; Hellstrom WJ
    Expert Opin Pharmacother; 2016 Dec; 17(17):2281-2289. PubMed ID: 27677349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Phosphodiesterase-5 Inhibitors in Valvular Heart Disease.
    Gopal A; Sharma T; Calkins JB
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):372-376. PubMed ID: 34074904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.
    Nehra A; Jackson G; Miner M; Billups KL; Burnett AL; Buvat J; Carson CC; Cunningham GR; Goldstein I; Guay AT; Hackett G; Kloner RA; Kostis J; Montorsi P; Ramsey M; Rosen RC; Sadovsky R; Seftel AD; Vlachopoulos C; Wu FC
    J Urol; 2013 Jun; 189(6):2031-8. PubMed ID: 23313195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of exercise capacity among men undergoing pharmacologic treatment for erectile dysfunction: The FIT Project.
    Same RV; Al Rifai M; Feldman DI; Billups KL; Brawner CA; Dardari ZA; Ehrman JK; Keteyian SJ; Al-Mallah MH; Blaha MJ
    Clin Cardiol; 2017 Nov; 40(11):1049-1054. PubMed ID: 28805967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic therapy for erectile dysfunction and its interaction with the cardiovascular system.
    Ioakeimidis N; Kostis JB
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):53-64. PubMed ID: 24281316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: A retrospective, observational study based on healthcare claims and national death index data.
    Kloner RA; Stanek E; Crowe CL; Singhal M; Pepe RS; Bradsher J; Rosen RC
    J Sex Med; 2023 Jan; 20(1):38-48. PubMed ID: 36897243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of erectile dysfunction and peculiarities of its treatment in men with high cardiovascular risk].
    Mamedov MN; Digigova RT; Sharvadze GG; Ugurchieva ZO; Kovrigina MN; Stroeva MV
    Kardiologiia; 2010; 50(11):85-90. PubMed ID: 21526570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPH/LUTS and ED: common pharmacological pathways for a common treatment.
    Fusco F; D'Anzeo G; Sessa A; Pace G; Rossi A; Capece M; d'Emmanuele di Villa Bianca R
    J Sex Med; 2013 Oct; 10(10):2382-93. PubMed ID: 23875757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
    Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
    Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.